Criminalization and Drug “Wars” or Medicalization and Health “Epidemics”: How Race, Class, and Neoliberal Politics Influence Drug Laws
This essay argues that race and class influence drug laws through politicized means. Crack-cocaine and methamphetamine production, sales, and use were met with criminalizing efforts because of their respective association with African Americans and poor Whites, two groups that have been differential...
Gespeichert in:
Veröffentlicht in: | Critical criminology (Richmond, B.C.) B.C.), 2019-06, Vol.27 (2), p.305-327 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This essay argues that race and class influence drug laws through politicized means. Crack-cocaine and methamphetamine production, sales, and use were met with criminalizing efforts because of their respective association with African Americans and poor Whites, two groups that have been differentially identified as threatening to hegemonic power. Despite some similarities in criminalizing outcomes, specific reactions differed. Crack-cocaine’s publicized connection to violence resulted in extensive surveillance, arrest, and imprisonment. Attention surrounding methamphetamine, however, often linked the drug to safety hazards, including property explosions, physical distortions of users, and the pathology of un(der)employment. As a result, policing the methamphetamine problem increased detentions but not to the same extent as crack-cocaine. I contend that the current opioid “epidemic” has received more medicalized reactions due to opiate’s association to middle- and upper-class Whites—social groups that are traditionally protected. I conclude by proposing that despite nuanced and unique consequences of criminalizing and medicalizing responses, each reflects a neoliberalist agenda that seeks to diffuse social threat and reinforce prevailing inequalities. |
---|---|
ISSN: | 1205-8629 1572-9877 |
DOI: | 10.1007/s10612-018-9398-7 |